Next Article in Journal
Mettl3 Regulates Osteogenic Differentiation and Alternative Splicing of Vegfa in Bone Marrow Mesenchymal Stem Cells
Next Article in Special Issue
Novel Approaches for the Treatment of Alzheimer’s and Parkinson’s Disease
Previous Article in Journal
Structural Perspective on Revealing and Altering Molecular Functions of Genetic Variants Linked with Diseases
Previous Article in Special Issue
Post-Injury Neuroprotective Effects of the Thalidomide Analog 3,6′-Dithiothalidomide on Traumatic Brain Injury
Open AccessReview

A Systematic Review of Neuroprotective Strategies in the Management of Hypoglycemia

1
Department of Neurology, Jena University Hospital - Friedrich Schiller University, Jena 07747, Germany
2
Institute for Biochemistry II, Jena University Hospital - Friedrich Schiller University, Jena 07743, Germany
3
Orthopedic Department, Jena University Hospital - Friedrich Schiller University, Campus Eisenberg, Klosterlausnitzer Straße 81, Eisenberg 07607, Germany
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(3), 550; https://doi.org/10.3390/ijms20030550
Received: 30 December 2018 / Revised: 18 January 2019 / Accepted: 24 January 2019 / Published: 28 January 2019
(This article belongs to the Special Issue Neuroprotective Strategies 2018)
Severe hypogylcemia has been found to induce cerebral damage. While a number of illnesses can lead to hypoglycemic episodes, antidiabetic medications prescribed for glycemic control are a common cause. Considering the rising prevalence of diabetes mellitus in the population, we investigated neuroprotective strategies during hypoglycemia in the form of a systematic review in adherence to the PRISMA statement. A review protocol was registered in the PROSPERO database. A systematic literature search of PubMed, Web of Science, and CENTRAL was performed in September 2018. Based on a predefined inclusion protocol, results were screened and evaluated by two researchers. Both animal experiments and human studies were included, and their risk of bias was assessed with SYRCLE’s and the Cochrane risk of bias tools, respectively. Of a total of 16,230 results, 145 were assessed in full-text form: 27 articles adhered to the inclusion criteria and were qualitatively analyzed. The retrieved neuroprotective strategies could be categorized into three subsets: (1) Energy substitution, (2) hypoglycemia unawareness, and (3) other neuroprotective strategies. While on a study level, the individual results appeared promising, more research is required to investigate not only specific neuroprotective strategies against hypoglycemic cerebral damage, but also its underlying pathophysiological mechanisms. View Full-Text
Keywords: hypoglycemia; neuroprotection; diabetes hypoglycemia; neuroprotection; diabetes
Show Figures

Figure 1

MDPI and ACS Style

Nistor, M.; Schmidt, M.; Graul, I.; Rakers, F.; Schiffner, R. A Systematic Review of Neuroprotective Strategies in the Management of Hypoglycemia. Int. J. Mol. Sci. 2019, 20, 550.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop